Skip to content
★ Sign in to follow
刘

刘兵

Board Director
Director
奥翔药业
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€1.7M

Latest filing published 14 Dec 2022 for 奥翔药业, €588k.

Filing timeline

BuySale
刘兵

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

刘兵: trading record in brief

刘兵, listed as board member, appears in our data through filings on 奥翔药业 shares, published by SSE / SZSE (CSRC). We count 4 filings; the first trade dates from 8 July 2022 and the latest from 14 December 2022.

The open-market record consists of 4 sales worth €1.7M, with no purchase.

Most recently, on 14 December 2022, the filings show an open-market sale worth €588k in 奥翔药业. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Companies and markets linked to 刘兵

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▼
    董事Executives奥翔药业
    4M CNY26SSE
    150,000 shares35.3% of flowA股XSHGSSE:173000006130584130
  • ▼
    董事Executives奥翔药业
    3M CNY22SSE
    120,000 shares25.7% of flowA股XSHGSSE:173000006124196670
  • ▼
    董事Executives奥翔药业
    991,131 CNY8SSE
    20,100 shares8.6% of flowA股XSHGSSE:173000005700564450
  • ▼
    董事Executives奥翔药业
    3M CNY10SSE
    70,000 shares30.4% of flowA股XSHGSSE:173000005662403420

4 of 4 declarations